bpc-157 fda advisory committee recommends compounding peptides like and TB-500 Big news for the peptide

Pharmacokinetic studies show that AOD 9604 has a short plasma half-life with rapid metabolism into active fragments

The AOD designation stands for Anti-Obesity Drug, reflecting the original research objective when the compound was developed by scientists at Metabolic Pharmaceuticals in the 1990s

[DOI] [PubMed] [Google Scholar] 28.Ntshingila S., Oputu O., Arowolo A.T., Khumalo N.P

Some vitamins cannot be delivered directly into a vein and thus require injection into the muscle or fat layer beneath the skin

For in-vitro research and laboratory use only

B12 injections are particularly beneficial for individuals with absorption issues, such as those with pernicious anemia or digestive disorders